The era of weight-loss drugs is officially here. Fuelled by blockbuster marvels like Ozempic and Mounjaro, which were developed to treat type 2 diabetes, pharmaceutical companies and their share holders have been making billions thanks to a number of targeted obesity medications, including Wegovy and Zepound. But the current boom is just the beginning.

Scores of other weight management drugs are in development, with their potential extending far beyond shrinking waistlines. Rather, these wonder medications are showing remarkable promise in treating everything from heart failure and liver disease to Alzheimer's, depression, and even addiction. Read on for the inside story on the weight-loss drug boom, the race for the "Holy Grail" and the exciting possibilities that lie ahead. 

All dollar amounts in US dollars